Related Experiment Video
Updated: Jul 20, 2025

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Congenital Heart Defects and Outcome in a Large Cohort of Down Syndrome: A Single-Center Experience from Turkey
Dilek Uludağ Alkaya1, Birol Öztürk2, Aylin Yüksel Ülker1
1Department of Pediatric Genetics, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
Insights
Congenital heart defects (CHDs) affect over half of Down syndrome patients, with ventricular septal defect being most common. Survival rates vary by defect severity, highlighting the need for specialized care.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Congenital heart defects (CHDs) are prevalent in Down syndrome, significantly impacting patient morbidity and mortality.
- Understanding the specific types and outcomes of CHDs in this population is crucial for effective management.
Purpose of the Study:
- To determine the prevalence, classification, and survival rates of congenital heart defects in individuals with Down syndrome.
- To identify prognostic factors influencing outcomes in Down syndrome patients with CHDs.
Main Methods:
- A retrospective analysis of 1731 Down syndrome patients who underwent echocardiography between 1986 and 2022.
- Classification of CHDs into cyanotic and acyanotic groups, with a median follow-up of 8.7 years.
Main Results:
- Over half (52.1%) of Down syndrome patients had CHDs, more common in females.
- Ventricular septal defect (35%) was the most frequent CHD, followed by atrial septal defect (31.8%) and atrioventricular septal defect (23.4%).
- Five-year survival rates were 97.4% (no CHD), 95.6% (mild CHD), and 86.1% (moderate to severe CHD).
Conclusions:
- Congenital heart defects are highly prevalent in Down syndrome, with VSD being the most common type.
- Survival is significantly impacted by the severity of the congenital heart defect.
- This large single-center study provides valuable insights into CHD classification, prognosis, and survival in Down syndrome patients.
Objective:
Congenital heart defects occur in approximately 50% of children with Down syndrome and they contribute considerably to morbidity and mortality. The aim of this study is to investigate the prevalence, classification, and survival of congenital heart defects in Down syndrome.
Materials And Methods:
About 1731 Down syndrome patients who underwent echocardiography between 1986 and 2022 were evaluated. The median follow-up duration was 8.7 years (range 1-35.8 years). Congenital heart defect was grouped as cyanotic and acyanotic.
Results:
Among the 1731 patients, 52.1% had congenital heart defects. Congenital heart defect was significantly more common in females than males. The most common cardiac defect was ventricular septal defect (35%), followed by atrial septal defect (31.8%), atrioventricular septal defect (23.4%), tetralogy of Fallot (5%), and patent ductus arteriosus (3.6%). In the follow-up, 43.2% of atrial septal defect, 17.8% of ventricular septal defect, and a total of 20% of congenital heart defects were closed spontaneously. About 34.4% of congenital heart defect was corrected by cardiac surgery/intervention. Five-year survival rate was 97.4% in patients without congenital heart defects, whereas it was 95.6% in mild congenital heart defects and 86.1% in moderate to severe congenital heart defects. There was no relationship between consanguinity, parental age, maternal disease, folic acid supplementation before/during pregnancy, gestational age, birth weight, and congenital heart defects. Neuromotor development was similar in patients with and without congenital heart defects.
Conclusion:
We demonstrated that almost half of the patients had congenital heart defects; ventricular septal defect was the most common congenital heart defect type. This study is valuable in terms of the largest single-center study describing the classification, prognostic factors, and survival of Down syndrome patients with congenital heart defect from Turkey.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Teratogenicity
Meiosis I
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy

